MERCK & CO, INC. for MERCK & CO INC
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Renewal and expansion of the R&D tax credit, miscellaneous corporate tax provisions (H.R. 4853)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON BENJAMIN VAN PELT | — |
Copyright/Patent/Trademark CPT
Settlement of patent litigation (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELI JOSEPH | — |
Health Issues HCR
Health Care Reform implementation; Awareness and treatment of viral hepatitis; Implementation of the Independent Payment Advisory Board provisions of health care reform bill (H.R. 3590); Reauthorization of the Prescription Drug User Fee Act (no specific bill); Importation of pharmaceuticals from foreign markets.
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTORIA BLATTER | — |
| ERIN DARLING | — |
| ANNE ESPOSITO | — |
| JEROME MURRAY | — |
Budget/Appropriations BUD
Increased funding for CDC's National Immunization Program (Sec. 317 Program); Increased funding for the AIDS Drug Assistance Program and for the Division of Viral Hepatitis at CDC (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELI JOSEPH | — |
| JEROME MURRAY | — |
Chemicals/Chemical Industry CHM
Pharmaceuticals in the environment (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELI JOSEPH | — |
Consumer Issues/Safety/Products CSP
Access to over-the-counter medications (no specific legislation).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELI JOSEPH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.